Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00830557 · ClinicalTrials.gov registry record
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
A clinical trial of Pancreatic Cancer and Pancreatic Adenocarcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 3
- Study locations
NCT00830557: Recruiting study of Pancreatic Cancer and Pancreatic Adenocarcinoma, sponsored by Mayo Clinic.
NCT00830557 is a study of Pancreatic Cancer and Pancreatic Adenocarcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 20,000 participants, above the 321-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (6131% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00830557, a study of Pancreatic Cancer and Pancreatic Adenocarcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.
Conditions Studied
Interventions
- OTHER medical chart review
- OTHER survey administration
- OTHER biospecimen collection
Study Locations (3)
Arizona
- Mayo Clinic Hospital in Arizona - Phoenix
Florida
- Mayo Clinic in Florida - Jacksonville
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2000-10-01 |
| Est. Completion | 2027-08-30 |
What NCT00830557 shows while recruiting
NCT00830557 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 321-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (6131% higher).
The record links to 8 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 3 interventions - of which medical chart review is the first listed.
NCT00830557 reports a single indexed study location in Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00830557 about?
NCT00830557 is a clinical study titled "Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders". RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medic...
What is the current status of trial NCT00830557?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2000-10-01. Estimated completion is 2027-08-30.
What conditions does trial NCT00830557 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Pancreatic Adenocarcinoma, Chronic Pancreatitis, Acute Pancreatitis, Pancreatic Disease.
What interventions are being tested in trial NCT00830557?
The interventions under investigation include: medical chart review (OTHER), survey administration (OTHER), biospecimen collection (OTHER).
Who is sponsoring clinical trial NCT00830557?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00830557 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00830557's enrollment target sits among peer trials
20,000 1st of 278 higher than 278 of 278 other Pancreatic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
RECRUITING · Phase 1
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- NCT03115710 · 20,000 participants
The K-Map Study, Global Prevalence of KC
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI